Predicting mortality in patients with ventilator- associated pneumonia: The APACHE II score versus the new IBMP-10 score

Clinical Infectious Diseases

Volumn 49, Issue 1, 2009, Pages 72-77

  Mirsaeidi, Mehdi ^a   Peyrani, Paula ^a   Ramirez, Julio A ^a,b  

^a University of Louisville School of Medicine   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; APACHE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE DEFICIENCY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 66949123514     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/599349     Document Type: Article

References (14)

1. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903.
2. Sinuff T, Muscedere J, Cook D, Dodek P, Heyland D. Ventilator-associated pneumonia: improving outcomes through guideline implementation. J Crit Care 2008;23:118-25.
3. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998; 129:433-40.
4. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159:1249-56.
5. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-29.
6. Gursel G, Demirtas S. Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia. Respiration 2006; 73:503-8.
7. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004; 53(RR-3):1-36.
8. Imai K, van Dyk DA. Causal inference with general treatment regimes: generalizing the propensity score. J Am Stat Assoc 2004; 99:854-66.
9. Zimmerman JE, Kramer AA, McNair DS, Malila FM, Shaffer VL. Intensive care unit length of stay: benchmarking based on Acute Physiology and Chronic Health Evaluation (APACHE) IV. Crit Care Med 2006;34:2517-29.
10. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44(Suppl 2):S27-72.
11. Tejerina E, Frutos-Vivar F, Restrepo MI, et al. Incidence, risk factors, and outcome of ventilator-associated pneumonia. J Crit Care 2006; 21:56-65.
12. Ibrahim EH, Tracy L, Hill C, Fraser VJ, Kollef MH. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest 2001; 120:555-61.
13. Chevret S, Hemmer M, Carlet J, Langer M. Incidence and risk factors of pneumonia acquired in intensive care units: results from a multi- center prospective study on 996 patients. European Cooperative Group on Nosocomial Pneumonia. Intensive Care Med 1993; 19:256-64.
14. Moine P, Timsit JF, De Lassence A, et al. Mortality associated with late- onset pneumonia in the intensive care unit: results of a multi-center cohort study. Intensive Care Med 2002; 28:154-63.